Atrial Fibrillation Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness a 3% CAGR from 2021 to 2027.

Atrial fibrillation is the most common persistent cardiac arrhythmia disorder worldwide. This leads to a chaotic rhythm due to the degeneration of electrical impulses that occur in the upper ventricle (atrium) of the heart. Old age, diabetes, high blood pressure, obesity, excessive alcohol consumption, chronic kidney disease, and ischemic heart disease are major risk factors for atrial fibrillation. According to the American Heart Association, individuals over the age of 40 have a lifetime risk of developing atrial fibrillation at 25%. Atrial fibrillation leads to increased hospitalization rates, poor quality of life, and increased risk of stroke and death. Atrial fibrillation medications are used to effectively manage disease by regulating heart rate and rhythm by preventing blood clots. Warfarin, Apixaban, Sotalol, Esmolol, Verapamil, and Dofetilide are some of the atrial fibrillation medications currently on the market.

Market Segments

Global Atrial Fibrillation Drugs Market, by Product

• Antiarrhythmic Drugs
• Anticoagulant Drugs

Global Atrial Fibrillation Drugs Market, by Type

• Paroxysmal
• Permanent
• Persistent

Global Atrial Fibrillation Drugs Market, by Application

• Heart Rate Control
• Heart Rhythm Control

Key Players

• Pfizer
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Sanofi
• Bristol-Myers Squibb Company
• Mitsubishi Tanabe Pharma Corporation
• Johnson and Johnson
• DAIICHI SANKYO COMPANY, LIMITED
• GlaxoSmithKline plc

Scope of the Report

The research study analyzes the global Atrial Fibrillation Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Atrial Fibrillation Drugs Market Report

1. What was the Atrial Fibrillation Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Atrial Fibrillation Drugs Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Atrial Fibrillation Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.